Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes

Francisco A Bonilla, MD, PhD
Section Editor
E Richard Stiehm, MD
Deputy Editor
Anna M Feldweg, MD


Immune system function is altered by many conditions which primarily impair function of other organ systems (table 1). As with primary immunodeficiency, secondary immune dysfunction leads to an increased incidence of infection and malignancy, and the occurrence of autoimmune disease.

The mechanisms and sequelae of the immune dysfunction, occurring as the result of biochemical abnormalities, environmental exposures, miscellaneous disorders, and infections other than human immunodeficiency virus (HIV) will be reviewed here. Secondary immunodeficiencies resulting from immunosuppressive agents and malignancy are discussed separately. (See "Secondary immunodeficiency induced by biologic therapies".)

Infection with the HIV and the acquired immunodeficiency syndrome (AIDS) constitute an entire discipline by themselves and are discussed separately in the appropriate topic reviews.


Disease processes that lead to chronic imbalances in hormones, nutrients, and toxic metabolic waste products in body fluids may have profound effects on the function of one or more components of the immune system. There are a great many diagnostic entities that may be grouped under this broad heading. It may be that many have as yet unknown effects on immune function. A few disorders where clinically significant immune dysfunction is regularly encountered are presented in this section.

Diabetes mellitus — Neutrophil dysfunction underlies much of the predisposition to fungal infections found in patients with diabetes [1]. In addition, poor peripheral circulation leads to skin ulceration and diminished delivery of neutrophils to sites of microbial entry. Some characteristic infectious complications of diabetes include disseminated candidiasis, rhinopulmonary zygomycosis (mucormycosis), and malignant otitis due to P. aeruginosa. Issues related to infection in patients with diabetes mellitus are reviewed in more detail separately. (See "Susceptibility to infections in persons with diabetes mellitus".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: May 2017. | This topic last updated: Dec 02, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. de Marie S. Diseases and drug-related interventions affecting host defence. Eur J Clin Microbiol Infect Dis 1993; 12 Suppl 1:S36.
  2. Donati D, Degiannis D, Homer L, et al. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 1991; 58:268.
  3. Santos JI. Nutrition, infection, and immunocompetence. Infect Dis Clin North Am 1994; 8:243.
  4. Sävendahl L, Underwood LE. Decreased interleukin-2 production from cultured peripheral blood mononuclear cells in human acute starvation. J Clin Endocrinol Metab 1997; 82:1177.
  5. Zaman K, Baqui AH, Yunus M, et al. Malnutrition, cell-mediated immune deficiency and acute upper respiratory infections in rural Bangladeshi children. Acta Paediatr 1997; 86:923.
  6. Faggioni R, Feingold KR, Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 15:2565.
  7. Corman LC. The relationship between nutrition, infection, and immunity. Med Clin North Am 1985; 69:519.
  8. Stiehm ER, Ochs HD, Winkelstein JA. Immunodeficiency disorders: General considerations. In: Immunologic disorders in infants and children, 5th ed, Stiehm ER, Ochs HD, Winkelstein JA. (Eds), Elsevier/Saunders, Philadelphia 2005. p.315.
  9. Harris RC, Ismail N. Extrarenal complications of the nephrotic syndrome. Am J Kidney Dis 1994; 23:477.
  10. Crew RJ, Radhakrishnan J, Appel G. Complications of the nephrotic syndrome and their treatment. Clin Nephrol 2004; 62:245.
  11. Akman S, Güven AG, Ince S, Yeğin O. IgG and IgG subclasses deficiency in children undergoing continuous ambulatory peritoneal dialysis and its provocative factors. Pediatr Int 2002; 44:273.
  12. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82:695.
  13. Vignes S, Carcelain G. Increased surface receptor Fas (CD95) levels on CD4+ lymphocytes in patients with primary intestinal lymphangiectasia. Scand J Gastroenterol 2009; 44:252.
  14. Orange JS, Geha RS, Bonilla FA. Acute chylothorax in children: selective retention of memory T cells and natural killer cells. J Pediatr 2003; 143:243.
  15. Brogan TV, Finn LS, Pyskaty DJ Jr, et al. Plastic bronchitis in children: a case series and review of the medical literature. Pediatr Pulmonol 2002; 34:482.
  16. Faist E, Schinkel C, Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20:454.
  17. Barlow Y. T lymphocytes and immunosuppression in the burned patient: a review. Burns 1994; 20:487.
  18. Anderson RE, Warner NL. Ionizing radiation and the immune response. Adv Immunol 1976; 24:215.
  19. Uh S, Lee SM, Kim HT, et al. The effect of radiation therapy on immune function in patients with squamous cell lung carcinoma. Chest 1994; 105:132.
  20. Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int J Radiat Biol 2008; 84:1.
  21. Beissert S, Loser K. Molecular and cellular mechanisms of photocarcinogenesis. Photochem Photobiol 2008; 84:29.
  22. Norval M, McLoone P, Lesiak A, Narbutt J. The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol 2008; 84:19.
  23. Muller HK, Malley RC, McGee HM, et al. Effect of UV radiation on the neonatal skin immune system- implications for melanoma. Photochem Photobiol 2008; 84:47.
  24. Karol MH, Stoliker D. Immunotoxicology: past, present, and future. Inhal Toxicol 1999; 11:523.
  25. Luster MI, Blank JA, Dean JH. Molecular and cellular basis of chemically induced immunotoxicity. Annu Rev Pharmacol Toxicol 1987; 27:23.
  26. Dietert RR. Developmental immunotoxicology: focus on health risks. Chem Res Toxicol 2009; 22:17.
  27. Dzik S, Blajchman MA, Blumberg N, et al. Current research on the immunomodulatory effect of allogeneic blood transfusion. Vox Sang 1996; 70:187.
  28. Carson JL, Altman DG, Duff A, et al. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion 1999; 39:694.
  29. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 1993; 33:754.
  30. Weinberg ED. Pregnancy-associated immune suppression: risks and mechanisms. Microb Pathog 1987; 3:393.
  31. Matthiesen L, Berg G, Ernerudh J, Håkansson L. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol 1996; 35:70.
  32. Irwin M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv Neuroimmunol 1994; 4:29.
  33. Glaser R, Rice J, Sheridan J, et al. Stress-related immune suppression: health implications. Brain Behav Immun 1987; 1:7.
  34. Taylor GR, Konstantinova I, Sonnenfeld G, Jennings R. Changes in the immune system during and after spaceflight. Adv Space Biol Med 1997; 6:1.
  35. Namazi MR. The cellular immunodeficiency associated with post-traumatic stress disorder may be the result of sympathetic overactivity and be correctable by beta-2-blockers. Neuro Endocrinol Lett 2003; 24:468.
  36. Marrack P, Kappler J. Subversion of the immune system by pathogens. Cell 1994; 76:323.
  37. Haase R, Kirschning CJ, Sing A, et al. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J Immunol 2003; 171:4294.
  38. Beckford AP, Kaschula RO, Stephen C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 1985; 68:858.
  39. Griffin DE. Measles virus-induced suppression of immune responses. Immunol Rev 2010; 236:176.
  40. Rinaldo CR Jr. Immune suppression by herpesviruses. Annu Rev Med 1990; 41:331.
  41. Koch S, Larbi A, Ozcelik D, et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007; 1114:23.
  42. Langley R, Patel D, Jackson N, et al. Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol 2010; 30:149.
  43. Reiner NE. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol Today 1994; 15:374.
  44. Dessaint JP, Capron A. Immunodeficiencies in parasitic diseases. Immunodefic Rev 1989; 1:311.
  45. Engelhorn S, Bruckner A, Remold HG. A soluble factor produced by inoculation of human monocytes with Leishmania donovani promastigotes suppresses IFN-gamma-dependent monocyte activation. J Immunol 1990; 145:2662.
  46. Tarleton RL. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J Immunol 1988; 140:2769.
  47. Abe T, Colley DG. Modulation of Schistosoma mansoni egg-induced granuloma formation. III. Evidence for an anti-idiotypic, I-J-positive, I-J-restricted, soluble T suppressor factor. J Immunol 1984; 132:2084.
  48. Sztein MB, Kierszenbaum F. A soluble factor from Trypanosoma brucei rhodesiense that prevents progression of activated human T lymphocytes through the cell cycle. Immunology 1991; 73:180.
  49. Magrath I, Jain V, Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol 1992; 3:285.
  50. de Thé G. The etiology of Burkitt's lymphoma and the history of the shaken dogmas. Blood Cells 1993; 19:667.
  51. Camus D, Nosseir A, Mazingue C, Capron A. Immunoregulation by Schistosoma mansoni. Immunopharmacology 1981; 3:193.
  52. Ottesen EA, Hiatt RA, Cheever AW, et al. The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol 1978; 33:37.
  53. Feldmeier H, Gastl GA, Poggensee U, et al. Relationship between intensity of infection and immunomodulation in human schistosomiasis. I. Lymphocyte subpopulations and specific antibody responses. Clin Exp Immunol 1985; 60:225.
  54. Greenwood BM, Whittle HC, Molyneux DH. Immunosuppression in Gambian trypanosomiasis. Trans R Soc Trop Med Hyg 1973; 67:846.